OVERVIEW

Neurology Consultations™: Coordinating Care Between the Neurologist and Pharmacist in Multiple Sclerosis Treatment is organized by Pharmacy Times Continuing Education (PTCE).This activity is approved for 1.25 contact hours (0.125 CEUs)

Dates:
Release Date: October 23, 2019
Expiration Date: October 23, 2020

Accreditation:
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.25 contact hours (0.125 CEUs) under the ACPE universal activity number 0290-9999-19-206-H01-P. The activity is available for CE credit through October 23, 2020.

Activity Overview:
This activity features the Neurology Consultations™ platform consisting of video clips featuring the latest clinical updates and case-based conversations between a neurologist and a pharmacist who specialize in the care of patients with multiple sclerosis. This online educational activity features 3 patient case scenarios addressing topics such as family planning in the era of disease-modifying therapies, magnetic resonance imaging as a tool to inform clinical decisions, opportunities for patients whose platform therapies have failed, and other interesting clinical issues in multiple sclerosis.

Educational Objectives:
Upon completion of this educational activity, participants will be able to:
• Recognize the importance of early diagnosis and treatments of MS using efficacious disease-modifying therapy (DMT).
• Describe best practices for effective communication and coordination between specialty pharmacists and neurologists to optimize patient outcomes.
• Analyze data from recent clinical trials to determine the role of novel DMTs in the existing treatment landscape and the potential for improving clinical outcomes.